Visual theranostic oral nanozymes for IBD from principles to preclinical design
Shangyong Zuo, Kefan Li, Liang Feng, Xingyan Yu, Yifan Wang, Chengwei Wu, Wenjian Weng, Yaoting He, Xiujun Cai, Kui Cheng · 2026
Read Visual theranostic oral nanozymes for IBD from principles to preclinical design by Shangyong Zuo, Kefan Li, Liang Feng, Xingyan Yu, Yifan Wang, Chengwei Wu, Wenjian Weng, Yaoting He, Xiujun Cai, Kui Cheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13316763.txt.
Description
Shangyong Zuo and co-authors review, in a 2026 article, oral nanozymes built to treat inflammatory bowel disease while also lighting it up on scans. These enzyme-like particles can mop up harmful oxygen radicals in the gut wall, where inflammation, oxidation, and barrier damage feed each other.
The review sorts designs into single-signal approaches, guided by CT or by light and sound imaging, and combined approaches that merge structure and function on one platform. Swallowed particles must survive the gut, prove their enzyme action, and stay safe long term, all open problems the authors flag. Their design principles aim at particles that both heal and report, sharpening early testing in animals.
Catalog record
| CREATOR | Shangyong Zuo, Kefan Li, Liang Feng, Xingyan Yu, Yifan Wang, Chengwei Wu, Wenjian Weng, Yaoting He, Xiujun Cai, Kui Cheng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 107961 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |